Abatacept in Immune Checkpoint Inhibitor Myocarditis

Clinical trial NCT05335928 · RECRUITING

Trial details

NCT number: NCT05335928
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myocarditis Acute Cancer

Start date: 2022-07-02
Primary completion: 2026-11-20
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.